Simplified Synthesis of Dicoumarol-Based Copolyester for Anticancer Drug Delivery

A novel dicoumarol-based copolyester was synthesized via a one-step polycondensation reaction using titanium tetraisopropoxide (TTIP) as a catalyst. The copolyester was characterized using Fourier transform infrared spectroscopy (FT-IR), Nuclear Magnetic Resonance (NMR) spectroscopy (1H and 13C), an...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Chemistry 2024-08, Vol.6 (4), p.794-804
Hauptverfasser: Jaikumar, Gowsika, Veerabagu, Udayakumar, Kikas, Timo, Shanmugam, Sabarathinam
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:A novel dicoumarol-based copolyester was synthesized via a one-step polycondensation reaction using titanium tetraisopropoxide (TTIP) as a catalyst. The copolyester was characterized using Fourier transform infrared spectroscopy (FT-IR), Nuclear Magnetic Resonance (NMR) spectroscopy (1H and 13C), and Differential Scanning Calorimetry (DSC). Scanning electron microscopy (SEM) was used to examine the surface morphology before and after degradation. The synthesized copolyester exhibited toxicity against MCF-7 breast cancer cells, with an IC[sub.50] value of 62.5 μg/mL, and demonstrated potential as a drug carrier with a consistent drug-release rate. The combination of dicoumarol, itaconic acid, and 1,12-dodecanediol in the copolyester enhances its biomedical capabilities, with dicoumarol providing anticancer properties, itaconic acid offering biocompatibility and mechanical stability, and 1,12-dodecanediol ensuring structural integrity and responsiveness. This study presents the first example of a dicoumarol-substituted copolyester, which was thoroughly characterized and shown to have promising biocompatibility for targeted anticancer therapy. The synthesis of this novel copolyester from renewable sources highlights the growing interest in sustainable materials for pharmaceutical and biomedical applications, particularly in drug delivery and tissue engineering for cancer treatment.
ISSN:2624-8549
DOI:10.3390/chemistry6040047